Zusammenfassung
Die arterielle Hypertonie rangiert unter den Todesursachen sehr hoch und ist mehr als jede andere Krankheit für subjektive und objektive Erscheinungen am Herzen verantwortlich.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Schrifttum
Allan, A. W. “Heredity in Hypertension: a Statistical Study.” Arch. Int. Med., 52, 954, 1933.
Allbutt, C. “Diseases of the Arteries.” London, 1915.
Alvarez, W. C., Wulzen, R., and Mahoney, L. J. “Blood Pressures in, Fifteen Thousand University Freshmen.” Arch. Int. Med., 32, 17, 1923.
Ambard, L. and Beauyard, E., La rétention chlorurée sèche, Semaine Medicale, 25, 133, 1905.
American Heart Association, Committee for the Standardization of Blood Pressure Readings. “Standard Method for taking and recording Blood Pressure Readings.” J. A. M. A., 113, 294, 1939.
Amsterdam, B., and Amsterdam, A. L. “Disparity in Blood Pressures in Both Arms in Normals and Hypertensives and its Clinical Significance.” New York State J. Med., 43, 2294, 1943.
Ayman, D., An evaluation of therapeutic results in essential hypertension, J. A. M. A., 95, 246, 1930.
Ayman, D., “The Personality Type of Patients with Arteriolar Essential Hypertension.” Am. J. M. Sc., 186, 213, 1933.
Ayman, D., “Heredity in Arteriolar (Essential) Hypertension.” Arch. Int. Med., 53, 792, 1934.
Barker, M. H. “The Blood Cyanates in the Treatment of Hypertension.” J. A. M. A., 106, 762, 1936.
Barker, N. W., and Walters, W. “Hypertension associated with Unilateral Chronic Atrophic Pyelonephritis: Treatment by Nephrectomy.” Proc. Staff Meet., Mayo Clin., 13, 118, 1938.
von Basch, R. Über latente Arteriosklerose und deren Beziehung zu Fettleibigkeit. Herzerkrankungen und anderen Begleiterscheinungen. Wien, Urban & Schwarzenberg, 1893.
Battro, A., Braun-Menendez, E., Lanari, A., Leloir, L. F. “Accion presorts en el hombre de la renina y de la hipertensina.” Rev. Soc. argent. de biol., 16, 376, 1940.
Berry, M. R., Jr. “The Mechanism and Prevention of Impairment of Auscultatory Sounds during Determination of Blood Pressure of Standing Patients.” Proc. Staff Meet., Mayo Clin., 15, 699, 1940.
Bechgaard, P. and Hammerstroem, S., Surgical treatment of arterial hypertension, Acta chir. stand., Suppl. 155, 1950.
Bickel, H. Über die normale und pathologische Reaktion des Blutkreislaufs auf psychische Vorgänge. Neurol. Centralbl., 33, 90, 1914.
Bing, R. J. “The Formation of Hydroxytyramine by Extracts of Renal Cortex and by Perfused Kidneys.” Am. J. Physiol., 132, 497, 1941.
Bing, R. J., Thomas, C. B. and Waples, E. C., The circulation in experimental neurogenic hypertension, J. clin. Inv., 24, 513, 1945.
Bingel, A., und Strauß, E. Über die blutdrucksteigernde Substanz der Niere. Deutsches Arch. f. klin Med., 96, 476, 1909.
Boas, E. P., and Shapiro, S. “Diastolic Hypertension with Increased Basal Metabolic Rate.” J. A. M. A., 84, 1558, 1925.
Bordley, J. III and Baker, B. M., Jr. “A Consideration of Arteriosclerosis of the Cerebral Vessels and the Pathogenesis of Hypertension.” Bull. Johns Hopkins Hosp., 39, 228, 1926.
Borst, J. G. G., Protein Katabolism in uremia, Lancet, 1, 824, 1948.
Bowers, R. F., Adrenalectomy for hypertension, Surgery, 34, 664, 1953.
Braun-Menendez, E., Fasciolo, J. C., Leboir, L. F., and Munoz, J. M. “The Substanc causing Renal Hypertension.” J. Physiol., 98, 283, 1940.
Brown, G. E., and Rowntree, L. G. “Right-sided Carotid Pulsations in Cases of Severe Hypertension.” J. A. M. A., 84, 1016, 1925.
Brozek, J., Chapman, C. B. and Keys, A., Drastic food restriction, J. A. M. A., 137, 1569, 1948.
Buchem van, F. S. P., The hypertensive diencephalic syndrome, Acta Med. Scand., 130, 575, 1948.
Burgess, A. M., Excessive hypertension of long duration, New Engl. J. Med., 239, 75, 1948.
Butler, A. M. “Chronic Pyelonephritis and Arterial Hypertension.” J. Clin. Investigation, 16, 889, 1937.
Bruger, M. and Hollander, V. P., Extrathyrodal hypermetabolism, Ann. int. Med. 35, 1260, 1951.
Castleman, B., and Smithwick, R. H. “The Relation of Vascular Disease to the Hypertensive State.” J. A. M. A., 121, 1256, 1943.
Cook, J. E., and Taussig A. E. “Auscultatory Blood Pressure Determination, a Source of Possible Error.” J. A. M. A., 68, 1088, 1917.
Cossi, P., Moia, B., Fustinoni, O., Batlle, F. F. “Estudios clinicos sobre la hipertension arterial; caracteres del segundo ruido cardiaco.” Rev. argent. de cardiol., 5, 336, 1938.
Currens, J. H., Myers, G. S. and White, P. D., The use of protoveratrine in the treatment of hypertensive vascular disease, Am. Heart J., 46, 576, 1953.
Daley, R. M., Ungerleider, H. E., and Gubner, R. S. “Prognosis in Hypertension.” J. A. M. A., 121, 383, 1943.
Davidson, C., and Brill, N. Q. “Essential Hypertension and Chronic Hypertensive Encephalopathy.” Ann. Int. Med., 12, 1766, 1939.
Davis, D. and Klainer, M. J., Studies in hypertensive heart disease, Am. Heart J., 19, 193, 1940.
Derow, H. A., and Altschule, M. D. “Malignant Hypertension.” New England J. Med., 213, 951, 1935.
Diehl, H. S., and Sutherland, K. H. “Systolic Blood Pressures in Young Men including a Special Study of Those with Hypertension.” Arch. Int. Med., 36, 151, 1925.
Dixon, W. E., und Heller, H. Experimentelle Hypertonie durch Erhöhung des intrakraniellen Druckes. Arch. f. exper. Path. und Pharmakol., 166, 265, 1932.
Dunihue, F. W. “Effect of Cellophane Perinephritis on the Granular Cells of the Juxtaglomerular Apparatus.” Arch. Path., 32, 211, 1941.
Dustan, H. P., and assoc., Rheumatic and febrile syndrome during prolonged hydralazine treatment, J. A. M. A., 154, 23, 1954.
Eichna, L. W., Horwath, S. M., and Bean, W. B. “Post-exertional orthostatic hypotension.” Am. J. Med. scienc., 21,3 641, 1947.
Ellis, A. “Malignant Hypertension.” Lancet, I, 977, 1938.
Ellis, A. “Natural History of Bright’s Disease.” Lancet, I, 1, 1942.
Ellis, L. B., and Weiss, S. “The Measurement of Capillary Pressure under Natural Conditions and after Arteriolar Dilatation in Normal Subjects and in Patients with Arterial Hypertension and with Arteriosclerosis.” J. Clin. Investigation, 8, 47, 1929.
Elwyn, H. “Changes in the Fundus of the Eye in Various Forms of Arterial Hypertension.” Arch. Ophth., 31, 376, 1944.
Enger, R., Gerstner, H., and Sarre, H. Die Abhängigkeit der Nierendurchblutung vom Ureterendruck. Zentralbl. f. inn. Med., 58, 865, 1937.
Emlet, J. R., and assoc. “Use of piperoxan and regitine as routine tests in patients with hypertension.” J. A. M. A., 146, 1383, 1951.
Engel, A., and von Euler, U. S. “Diagnostic value of increased urinary output of nor-adrenaline and adrenaline in phaeochromocytoma.” Lancet, 2, 387, 1947.
Evelyn, K. A., Alexander, F., and Cooper, S. R. “Effect of sympathectomy on blood pressure in hypertension.” J. A. M. A., 140, 592, 1949.
Fahr, G. Handbuch d. spec. pathol. Anatom. u. Hist. Hencke, F. und Lubarsch, O. S. Springer, Berlin, 1925, Vol. 6.
Fahr T. “Maligne Hypertonie.” Klin. Wchnschr., 1939, p. 1541.
Fasciolo, J. C., Houssay, B. A., and Taquini, A. C. “The Blood-Pressure Raising Secretion of the Ischaemic Kidney.” J. Physiol., 94, 281, 1938.
Fishback, H. R., Dutra, F. E., and McCamy, E. T. “The Production of Chronic Hypertension in Dogs by Progressive Ligation of Arteries supplying the Head.” J. Lab. & Clin. Med., 28, 1187, 1943.
Fishberg, A. M. “Hypertension and Nephritis.” 4th Edition, Philadelphia, Lea & Febiger, 1939.
Fishberg, A. M. “Sympathectomy for essential hypertension.” J. A. M. A., 137, 670, 1948.
Floyer, M. A. “The effect of nephrectomy and adrenalectomy upon the blood pressure in hypertensive and normotensive rats.” Clin. Scienc., 10, 405, 1951.
Freeman, N. E., and Page, I. H. “Hypertension produced by Constriction of the Renal Artery in Sympathectomized Dogs.” Am. Heart J., 14, 405, 1937.
Gallavardin, L. “La tension arterielle en clinique.” 2. édition. Masson et Cie, Paris, 1921.
Gallavardin, L., and Tixier, L. “Dissociation sphygmomanométrique oscillatoire et vibro-ausculatatoire dans un case de rétrécissement aortique serré et insuffisance aortique avec pulsus tardus et anacrotisme.” Arch. d. mal. du coeur, 12, 447, 1919.
Gasul, B. M., Glasser, J. M., and Grossman, A. “Extreme hypertension in a child cured by nephrectomy.” J. A. M. A., 139, 305, 1949.
Gerbaux, A. “L’hypertension arterielle d’origine renale curable par nephrectomie chez l’homme.” Semaine Hopit. Paris, 26, 715, 1950.
Gibbs, D. F. “Dihrydrogenated alkaloids of ergot in the investigation and treatment of diastolic hypertension.” Brit. Heart J., 14, 77, 1952.
Gilliand, I. C., and Daniel, O. “Phaeochromocytoma presenting as an abdominal Emergency.” Brit. med. J., 2, 275, 1951.
Goetz, R. H. “The effect of sympathicolytic drugs on the cardiovascular system in man with special reference to hypertension.” Angiology, 2, 1, 1941.
Globus, J. H., and Strauss, I. “Massive Cerebral Hemorrhage: its Relations to Pre-existing Cerebral Softening.” Arch. Neurol. & Psychiat., 18, 215, 1927.
Goldblatt, H. “Experimental Hypertension induced by Renal Ischemia.” Bull. New York Acad. Med., 14, 523, 1938.
Goldblatt, H., Lunch, J., Hanzal, R. F., and Summerville, W. W. “Studies on Experimental Hypertension. I. The Production of Persistent Elevation of Systolic Blood Pressure by means of Renal Ischemia.” J. Exper. Med., 59, 347, 1934.
Goldenberg, M. “New test for hypertension due to circulating epinephrine.” J. A. M. A., 135, 971, 1947.
Goldenberg, M., and assoc. “The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension.” Am. J. Med., 5, 792, 1948.
Goldenberg, M., and assoc. “Pheochromocytoma and essential hypertensive vascular disease.” Arch. int. Med., 86, 823, 1950.
Goldenberg, M., and Aranow, H. Jr. “Diagnosis of pheochromocytoma by the adrenergic blocking action of benzodioxane.” J. A. M. A., 143, 1139, 1950.
Goldhammer, S., Leiner, G., und Scherf, D. Über die zirkulierende Blutmenge vor und nach der Quecksilberdiurese. Klin. Wchnschr., 14, 1109, 1935.
Goormaghtigh, N., and Grimson, K. S. “Vascular Changes in Renal Ischemia Cell Mitosis in the Media of Arteries.” Proc. Soc. Exp. Biol. & Med., 42, 227, 1939.
Graham, J. D. P. “High Blood-Pressure after Battle.” Lancet, I, 239, 1945.
Gregory, R., Lindley, E. L., and Levine, H. “Studies on Hypertension II: the Effect on the Renal function of decreasing the Blood Pressure of Patients with Hypertension.” Texas Rep. Biol. & Med., 1, 167, 1943.
Gressel, G. C. et al. “Personality factors in arterial hypertension.” J. A. M. A., 140, 265, 1949.
Grimson, K. S. “The Sympathetic Nervous System in Neurogenic and Renal Hypertension.” Arch. Surg., 43, 284, 1941.
Grollman, A. “Experimental Chronic Hypertension in the Rabbit.” Am. J. Physiol., 142, 666, 1944.
Hammarström, S. “Arterial hypertension.” Acta Med. Scand. Suppl. 192, 1947.
Hardgrove, M., Roth, G. M., and Brown, G. E. “The Pressor Reaction produced by Inhalation of Carbon Dioxide; Studies of Patients with Normal Blood Pressure and with Hypertension.” Ann. Int. Med., 12, 482, 1938.
Harrison, T. R., Blalock, A., and Mason, M. F. “Effects on Blood Pressure of Injection of Kidney Extracts of Dogs with Renal Hypertension.” Proc. Soc. Exper. Biol. & Med., 35, 38, 1936.
Hartwich, A. Der Blutdruck bei experimenteller Urämie und partieller Nierenausschaltung. Ztschr. f. d. ges. exper. Med., 69, 462, 1930.
Herxheimer, G. Über Arteriolonekrose der Nieren. Virchows Arch. f. path. Anat., 251, 709, 1924.
Hessel, G., und Maier-Hiiser, H. Über Das Renin, einen körpereigenen kreislaufwirksamen Stoff. Verhandlung d. deutsch. Gesellsch. f. inn. Med., Kong., 46, 347, 1934.
Heymans, C. Experimental-Arterial-Hypertension. New England J. Med., 219, 154, 1938.
Heymans, C. “Introduction to the regulation of blood pressure and heart rate.” Springfield, Thomas, 1950.
Heymans, C., and van den Heuvel-Heymans, G. “New aspects of blood pressure regulation.” Circulation, 4, 581, 1951.
Hines, E. A. Jr. “The hereditary factor and subsequent development of hypertension.” Proc. Staff. Meet. Mayo Clinic., 15, 145, 1940.
Heymans, C. “The Significance of Vascular Hyperreaction as measured by the Cold-Pressor Test.” Am. Heart J., 19, 408, 1940.
Holtz, P., und Heise, R. Fermentativer Abbau von 1-Dioxyphenylalanin (Dopa) durch die Niere. Arch. f. exper. Path. u. Pharmakol., 191, 87, 1938.
Houssay, B. A., and Fasciolo, J. C. “Secretion hipertensora del rinon isquemiado.” Rev. Soc. argent. de biol., 13, 284, 1937.
Houssay, B. A., and Taquini, A. C. “Mecanismo de la hipertension arterial de origen renal.” Rev. argent. de cardiol., 5, 291, 1938.
Howard, J. E., and Barker, W. H. “Paroxysmal hypertension and other clinical manifestations associated with benign chromaffin tumours.” Bull. J. Hopkins hosp., 61, 371, 1937.
Jeffers, W. A., and assoc. “Evaluation of adrenal resection and sympathectomy in ninety-nine persons with hypertension.” J. A. M. A., 153, 1502, 1953.
Johnson, R. P. “The treatment of hypertension with 1-Hydrazinophthalazine, (Apresoline).” Am. Heart J., 46, 593, 1953.
Kahler, H. Die Blutdrucksteigerung, ihre Entstehung und ihr Mechanismus. Ergebn. d. inn. Med. u. Kinderh., 25, 265, 1924.
Kaufman, M. “Pancytopenia following use of hydralazine (apresoline).” J. A. M. A., 151, 1488, 1953.
Keith, N. M., Wagener, H. O., and Barker, N. W. “Some Different Types of Essential Hypertension: their Course and Prognosis.” Am. J. M. Sc., 197, 332, 1939.
Kempner, W. “Treatment of kidney disease and hypertensive vascular disease with rice diet.” J. A. M. A., 125, 60, 1944.
Kempner, W. “Treatment of hypertensive vascular disease with rice diet.” Am. J. Med., 4, 545, 1948.
Kennedy, R. L. J., Barker, N. W., and Walters, W. “Malignant Hypertension; Cure following Nephrectomy: Follow-up Report of the Case of a Child.” Am. J. Dis. Child,. 69, 160, 1945.
Kert, M. J. et al. “Treatment of hypertension.” J. A. M. A., 143, 721, 1950.
Kezdi, P. “Sinoaortic regulatory system.” Arch. Int. Med., 91, 26, 1953.
Kimmelstiel, P., and Wilson, C. “Benign and Malignant Hypertension and Nephrosclerosis.” Am. I. Path., 12, 45, 1936.
Koch, E., und Mies, H. Chronischer arterieller Hochdruck durch experimentelle Dauerausschaltung der Blutdruckzügler. Krankheitsforschung, 7, 241, 1929.
Kolff, W. J. “Forced high caloric, low protein diet and the treatment of uremia.” Am. J. Med., 12, 667, 1952.
Kossman, C. E. “Relative importance of certain variables in the clinical determination of blood pressure.” Am. J., Med. 1, 464, 1946.
Laforet, E. S. “Malignant hypertension associated with unilateral renal artery occlusion.” Ann. Int. Med., 38, 667, 1953.
Lampert, H., and Müller, W. Beiwelchem Druck kommt es zu einer Ruptur der Gehirngefäße? Frankfurt. Ztschr. f. Path., 33, 471, 1926.
Leadbetter, W. F., and Burkland, C. E. “Hypertension in Unilateral Renal Disease.” J. Urol., 39, 611, 1938.
Levy, S. E., Mason, M. F., Harrison, T. R., and Blalock, A. “The Effects of Ureteral Occlusion on the Blood Flow and Oxygen Consumption of the Kidneys of Unanesthetized Dogs.” Surgery, 1, 238, 1937.
Lian, C., and Blondel, A. “L’hypotension artérielle orthostatique.” Paris Médical, I, 179, 1933.
Lorber, V., and Visscher, M. B. “The Action of Angiotonin on the Completely Isolated Mammalian Heart.” (Soc. proc.) Am. J. Physiol., 133, 365, 1941.
Loufbourow, D. G., and assoc. “The rice diet in ambulatory patients with essential hypertension.” N. Eng. J. Med., 244, 577, 1951.
Macheith, R. “Adrenal-sympathetic syndrome.” Brit. Heart J., 9, 1, 1944.
Maher, C. C., and Wosika, P. H. “Urologie Hypertension.” J. Urol., 41, 893, 1939.
Mannaberg, J. Weiteres über die Hochdrucktachykardie. Wien. Arch. f. inn. Med., 6, 147, 1923.
Martin, L. “Effect of weight-reduction on normal and raised blood-pressures in obesity.” Lancet, 2, 1051, 1952.
Master, A. M., Goldstein, I., and Walters, M. B. “New and old definitions of normal blood pressure; clinical significance of the newly established limits.” Bull. N. Y. Acad. Med., 27, 452, 1951.
Medical Research Council “The rice diet in the treatment of hypertension.” Lancet, 2, 509, 1950.
Medoff, H. S., and Bongiovanni, A. M. “Blood pressure in rats subjected to audiogenic stimulation.” Am. J. Physiol., 143, 300, 1945.
Meilman, E., and Krayer, O. “Clinical studies on Veratrum alkaloids.” Circulation, 1. 204, 1950.
Meilman, E., and Krayer, O. “Clinical studies on veratrum viride.” Circulation, 1, 204, 1950.
Miles, B. E. “The clinical significance of gallop rhythm in hypertension.” Brit. heart J., 13, 327, 1951.
Miller, S. I., Ford, R. V., and Moyer, J. H. “Dibenzyline: Results of therapy in patients with hypertension.” New Eng. J. Med., 248, 576, 1953.
Moia, B., and Quesada, R. “El tratamiento de la hipertension arterial por los rodanatos.” Rev. argent. de cardiol., 9, 41, 1942.
von Monakow, P., and Mayer, F. Über den Einfluß der Erschwerung des Harnabflusses auf die Nierenfunktion. Deutsches Arch. f. klin. Med., 128, 20, 1918.
Morrisey, D. M., Brookes, V. S., and Cooke, W. T. “Sympathectomy in the treatment of hypertension.” Lancet, 1, 403, 1953.
Morrow, J. D. “Studies on the control of hypertension by hyphex.” Circulation, 8, 829, 1953.
Moser, M., et al. “Chemical blockade of the sympathetic nervous system in essential hypertension.” Arch. Int. MVIed., 89, 708, 1952.
Mountain, G. E., Allen, E. V., and Haines, S. F. “The Basal Metabolic Rate in Essential Hypertension.” Am. Heart J., 26, 528, 1943.
Nichols, J. B. “The Pharmacologie and Therapeutic Properties of Sulphocyanates.” Am. J. M. Sc., 170, 735, 1925.
Nickerson, M. “Role of sympathetic blockade in the therapy of hypertension.” Am. J. Med., 8, 342, 1950.
Nordman, H., and Müller, O. Über die Lage eines blutdruckregulierenden Zentrums in der Medulla oblongata. Verh. dtsch. Ges. Krslffschg., 1932, p. 1945.
Nowak, S. J. G., and Walker, I. J. “Experimental Studies concerning the Nature of Hypertension.” New Eng. J. Med., 220, 269, 1939.
Nuzum, F. R., and Dalton, J. W. “Paroxysmal and Persistent Hypertension in Association with Lesions of the Adrenal Glands.” Am. Heart J., 16, 643, 1938.
Nuzum, F. R., Elliot, A. H., and Evans, R. D. “A Clinical and Pathological Study of Coronary Sclerosis: Its Incidence in Hypertension and Angina Pectoris.” Am. Heart J., 10, 367, 1935.
O’Hare, J. P., and Holden, R. B. “Longevity in benign essential hypertension.” J. A. M. A., 149, 1453, 1952.
Oster, W. “Transient Attacks of Aphasia and Paralyses in States of High Blood Pressure and Arterio-Sclerosis.” Canad. M. A. J., 1, 919, 1911.
Page, I. H. “A syndrome simulating diencephalic stimulation occurring in patients with essential hypertension.” Am. J. Med. Sc., 190, 9, 1935.
Page, I. H. “The Effect on Renal Efficiency of lowering Arterial Blood Pressure in Cases of Essential Hypertension and Nephritis.” J. Clin. Investigation, 13, 909, 1934.
Page, I. H. “Treatment of essential and malignant hypertension.” J. A. M. A., 147, 1311, 1951.
Page, I. H., and Helmer, O. M. “A Crystalline Pressor Substance (Angiotonin), resulting from the Reaction between Renin and Reninactivator.” J. Exper. Med., 71, 29, 1940.
Palmer, R. S. “Medical evaluation of the surgical treatment of hypertension.” J. A. M. A., 134, 9, 1947.
Parkinson, J., Bedford, D. E., and Almond, S. “Kinked Carotid Artery that Simulates Aneurysm.” Brit. Heart J., 1, 345, 1939.
Pauli, W. Über Ionenwirkungen und ihre therapeutische Verwendung. München. med. Wchnschr., 50, 153, 1903.
Peet, M. M., Woods, W. W., and Braden, S. “The Surgical Treatment of Hypertension.” J. A. M. A., 115, 1875, 1940.
Perry, H. M., and Schoeder, H. A. “Syndrome simulating collagen disease caused by hydralazine (Apresoline), J. A. M. A., 154, 670, 1954.
Peschel, E., and Peschel, R. L. “Electrolyte metabolism during rice diet.” Arch. Int. Med., 91, 296, 1953.
Pickering, G. W. “The pathogenesis of malignant hypertension.” Circulation, 6, 599, 1952.
Pickering, G. W. “Transient cerebral paralysis in hypertension and in cerebral embolism.” J. A. M.A., 137, 423, 1948.
Pickering, G. W. “The natural history of hypertension.” Brit. Med. Bull., 8, 305, 1952.
Pickering, G. W., and Kissin, M. “The Effects of Adrenaline and of Cold on the Blood Pressure in Human Hypertension.” Clin. Sc., 2, 201, 1936.
Pieri, G. “Tentativi di cura chirurgica dell’ipertensione arteriosa essenziale.” Riforma med., 48, 1173, 1932.
Pines, I., and Scherf, D. Über die auskultatorische Lücke. Klin. Wchnschr., 13, 1721, 1934.
Platt, R. “Heredity in hypertension.” Quart. J. Med., 16, 111, 1947.
Poppen, J. L., and Lemmon, C. “The surgical treatment of essential hypertension.” J. A. M. A., 134, 1, 1947.
Pratt, J. H. “Fifty years blood pressure record in a case of benign hypertension.” Bull. N. Eng. Med. Cent., 15, 156, 1953.
Proger, S. “Obesity and heart disease.” Med. Clin. N. Am., Sept. 1951, p. 1351.
Raab, W. Die Beziehungen zwischen CO2-Spannung und Blutdruck bei Normalen und Hypertonikern. Ztschr. f. d. ges. exp. Med., 68, 337, 1929.
Raab, W. Alimentäre Faktoren in der Entstehung von Arteriosklerose und Hypertension, Med. Klin., 28, 521, 1932.
Raab, W. Anfälle von Fieber, Hochdruck und Tachykardie nach Gehirnerschütterung. Ztschr. klin. Med., 136, 362, 1939.
Raab, W. “Cardiotoxic Substances in the Blood and Heart Muscle in Uremia (Their Nature and Action).” Journ. Lab. & Clin. Med., 29, 715, 1944.
Raab, W. “Central Vasomotor Irritability; Contribution to the Problem of Essential Hypertension.” Arch. Int. Med., 47, 727, 1931.
Raab, W. Die koordinierte Rolle von Nerven, Hormonen und Elektrolyten in der Pathophysiologie des Blutdruckes.“ Acta neuroveget., 6, 52, 1953.
Raab, W. Die zentrogenen Formen des arteriellen Hochdruckes. Ergebn. d. inn. Med. u. Kinderh., 46, 452, 1934.
Raab, W. Hypertension and tachycardia due to concussion of the brain. A. heart J., 37, 237, 1949.
Raab, W. Neurohormonal factors in the origin and treatment of cardiovascular disease. Bull. New Eng. Med. Cent., 7, 125, 1945.
Raab, W., and others. “Pressor effects of epinephrine, norepinephrine and dexoxycorticosterone acetate (DCA)weakened by sodium withdrawal.” Circul. 6, 373, 1952.
Ragan, C., and Boîdley, J., III. “The Accuracy of Clinical Measurements of Arterial Blood Pressure.” Bull. Johns Hopkins Hosp., 69, 504, 1941.
Rasolt, H. Über den Einfluß der Kammerfrequenz auf den Blutdruck bei einem Falle von instabilem Block. Wien. Arch. f. inn. Med., 17, 357, 1929.
Ray, B. S. “The surgical treatment of hypertensive vascular disease.” North Am. Med. Clinics, May page 735, 1949.
Robinson, S. C. “Hypotension: the ideal normal blood pressure.” New Eng J Med., 223, 407, 1940.
Robinson, S. C., and Brucer, M. “Range of normal blood pressure.” Arch. int. Med., 64, 409, 1939.
Rogen, A. S. “Paroxysmal hypertension.” Lancet, 1, 103, 1947.
Rogers, W. F., and Palmer, R. S. “Transient Nervous Hypertension as a Military Risk: Its Relation to Essential Hypertension.” New England J. Med., 230, 39, 1944.
Rosenheim, M. L., and Kauntze, R., Discussion on the Medical treatment of hypertension, Proc. Roy. Soc. Med. London, 45, 269, 1952.
Rothermich, N. O. An unusual case of pheochromocytoma with fatal outcome, Ann. int. Med., 36, 157, 1952.
Ruskin, A. and Beard, O. W., The Texas City disaster, Texas Rep. Biol. Med., 6, 234, 1948.
Sahli, IL, Herzmittel und Vasomotorenmittel, Verh. d. Kongr. inn. Med., 19, 45, 1901.
Salus, F. Zur Frage des bulbären Hochdruckes. Klin. Wchnschr., 11, 1152, 1932.
Saint-Pierre, H., Corcoran, A. C., Taylor, R. D. and Dustan, H. P., Relief of hypertensive headache by intravenous injection of thiocyanate, J. A. M. A., 152,493, 1953.
Schaefer, R. I., Menopausal hypertension, Endocrinology, 19, 705, 1935.
Scherf, D. “The Short P—R Interval and its Occurrence in Hypertension.” Bull. New York M. College, Flower & Fifth Ave. Hosps., 4, 116, 1941.
Schönemann. Die Veränderungen der Nasenschleimhautgefäße bei Nephritis. Arch. f. Laryngol. u. Rhinol., 12, 437, 1901/02.
Schott, A. “Spontaneous Fluctuations of Blood Pressure.” Guy’s Hosp. Rep., 86, 69, 1936.
Schottstaedt, M. F. and Sokolow, M., The natural history and course of hypertension with papilledema (malignant hypertension), Am. heart J., 45, 331, 1953.
Schroeder, H. A., and Steele, J. M. “Studies on `Essential’ Hypertension. II. The Association of Hypertension with Organic Renal Disease.” Arch. Int. Med., 68, 261, 1941.
Schroeder, H. A., and Goldman, M. L., Test for the presence of the “hypertensive diencephalic syndrome”, Am. J. Med., 6, 162, 1949.
Schroeder, H. A., Pathogenesis of hypertension, Am. J. Med., 10, 189, 1951.
Schroeder, H. A., The control of hypertension by hexamethonium and 1-hydrazinophthalazine, Arch. int. Med., 89, 523, 1952.
Schroeder, H. A., and Morrow, J. D., The control of arterial hypertension by Hyphex, Med. Clin. North Am., 37, 991, 1953.
Schroeder, H. A., Hypertensive diseases, Phildelphia, Lea and Febiger, 1953.
Schwab, E. H., and Schulze, V. E. “Heart Disease in the American Negro of the South.” Am. Heart J., 7, 710, 1932.
Selye, H., The general adaptation syndrome, J. Clin. Endocrin., 6, 117, 1946.
Selye, H., The alarm reaction and diseases of adaptation, Ann. Int. Med., 29, 403, 1948.
Selye, H., Role of somatotrophic hormone in the production of malignant nephrosclerosis, periarteritis nodosa and hypertensive disease, Brit. Med. J., 1, 263, 1951.
Sensenbach, W. “Effects of Unilateral Nephrectomy in Treatment of Hypertension.” Arch. Int. Med., 73, 123, 1944.
Shapiro, S. “Report of a Case of Essential Hypertension of more than Twenty-Five Years’ Duration showing no Renal Arteriolar Changes at Autopsy.” Journ. Lab & Clin. Med., 24, 60, 1938/39.
Shorr, E., Participation of hepatorenal vasotropic factors in experimental renal hypertension, Am. J. Med., 4, 120, 1948.
Shure, N. M. “Pyelonephritis and Hypertension.” Arch. Int. Med., 70, 284, 1942.
Smirk, F. H., Pathogenesis of essential hypertension, Brit. med. J., 1, 791, 1949.
Smith, H. W., Hypertension and urologie disease, Am. J. Med., 4, 724, 1948.
Smithwick, R. H. “A Technic for Splanchnic Resection for Hypertension.” Surgery, 7, 1, 1940.
Smithwick, R. H. “Surgical Treatment of Hypertension: the Effect of Radical (Lumbodorsal) Splanchnicectomy on the Hypertensive State of One Hundred and Fifty-Six Patients followed One to Five Years.” Arch. Surg., 49, 180, 1944.
Smithwick, R. H., and Thompson, J. E., Splanchnicectomy for essential hypertension, J. A. M. A., 152, 1501, 1953.
Stein, I., Transient “O” diastolic blood pressure, (indirect) in the upper extremities, Ann. int. Med., 30, 615, 1949.
Strisower, R., Über bedeutende Blutdrucksenkung nach Arbeit und bei Änderung der Körperlage bei Tabes dorsalis, Z. klin. Med., 117, 384, 1931.
Tandowsky, R. M., Clinical evaluation of combined hydrogenated alkaloids (Hydergine) in arterial hypertension, Circul. 9, 48, 1954.
Taussig, H. B., and Remsen, D. B. “Essential Hypertension in Boy of Two Years of Age.” Bull. Johns Hopkins Hosp., 58, 183, 1935.
Thomas, C. B., What is the mode of action of thiocyanate compounds in essential hypertension?, Ann. Int. Med., 37, 106, 1952.
Thorn, G. W. et al., Clinical studies on bilateral complete adrenalectomy, Ann. Int. Med., 37, 972, 1952.
Threefoot, S. A., Hypotension, Am. J. Med. scienc., 218, 86, 1949.
Tigerstedt, R., and Bergman, P. G. Niere und Kreislauf. Skand. Arch. Physiol., S, 223, 1898.
Vakil, R. J., A clinical trial of Rauwolfia serpentina in essential hypertension, Brit. heart J., 11, 350, 1949.
Voit, K., and Cyba, J. Das Verhalten des Blutdrucks bei Hyperventilation und Sauerstoffatmung. München. Med. Wchnschr., 80, 1466, 1933.
Volhard, F. and Fahr, T., Die Brightsche Nierenkrankheit, Berlin, Springer 1914.
Volhard, F., Die doppelseitigen hämatogenen Nierenerkrankungen. In: Mohr Stähelin Handbuch inn. Med. Berlin, 1918 and 1931.
Volhard, F., Über die Pathogenese des roten (essentiellen)arteriellen Hochdrucks und der malignen Sklerose, Schweiz. Med. Wchnschr. 87, 1189, 1948.
Wagener, H. P. and Keith, N. M., Diffuse arteriolar disease with hypertension and the associated retinal lesions, Medicine 18, 317, 1939.
Wald, M. H., Fierro, M. I. and Keeton, K. H., Toxic effects of 1-hydrazinophthalazine in ambulatory hypertensive patients, Am. Heart J., 46, 861, 1953.
Walter, C. W., and Pijoan, M. J. “Persistent Hypertension due to Hypothalamic Injury.” Surgery, 1, 282, 1937.
Watkin, D. M., Froeb, H. F., Hatch, F. T. and Gutman, A. B., Effects of diet in essential hypertension, Am. J. Med., 9, 428, 1950 and 9, 441, 1950.
Weiss, S., and Parker, F., Jr. “Pyelonephritis: Its Relation to Vascular Lesions and to Arterial Hypertension.” Medicine, 18, 221, 1939.
Weitz, W. Zur Ätiologie der genuinen oder vasculären Hypertension. Ztschr. f. klin. Med., 96, 151, 1923.
Westphal, K., und Bär, R. Über die Entstehung des Schlaganfalles. Deutsches Arch. f. klin. Med., 151, 1, 1926.
Westphal, K., und Blum, R. Die Rhodantherapie des genuinen arteriellen Hochdrucks und ihre theoretische Begründung. Deutsches Arch. f. klin. Med., 152, 331, 1926.
Wilbrandt, R., Treatment of hypertension with hydergine, Angiology, 4, 183, 1953.
Wilburne, M., Transient “O” diastolic brachial pressure (indirect) associated with normal or elevated popliteal pressure, tachycardia and nervous tension, Am. Heart J., 30, 381, 1945.
Wilkins, R. W. and Judson, W. E. The use of Rauwolfia serpentina in hypertension, New Engl. J. Med. 248, 48, 1953.
Wilson, C., and Byrom, F. B. “The Vicsious Circle in Chronic Bright’s Disease.” Quart. J. Med., 10, 65, 1941.
Wilson, C., Experimental hypertension, Brit. Med. Bill., S, 316, 1952.
Wilson, C., Renal factors in the production of hypertension, Lancet, 2, 579 and 632, 1953.
Wolf, S. et al., Hypertension as a reaction pattern to stress, Ann. Int. Med., 29, 1056, 1948.
Wolferth, C. C. et al., Effects of subtotal adrenalectomy alone and combined with sympathectomy upon the blood pressure levels and complications of severe arterial hypertension, Bull. N. Y. Acad. Med., 29, 115, 1953.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1955 Springer-Verlag
About this chapter
Cite this chapter
Scherf, D., Boyd, L.J. (1955). Hypertonie. In: Klinik und Therapie der Herzkrankheiten und der Gefäßerkrankungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7854-6_20
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7854-6_20
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7855-3
Online ISBN: 978-3-7091-7854-6
eBook Packages: Springer Book Archive